Skip to main content
Toggle navigation
Search
Home
Conference Program
Tweets by 2023 ASAM Annual Conference
Home
Poster Schedule
All Days
Fri, Apr 14
Sat, Apr 15
Poster Schedule
Type here to filter the list
Saturday, April 15, 2023
11:45 AM – 1:15 PM
(53) Opioid and Benzodiazepine Co-Prescribing at Emergency Department Discharge from 2012-2019
Favorite
11:45 AM – 1:15 PM
(54) Social Determinants of Health and Insomnia in People Receiving Buprenorphine for OUD
Favorite
11:45 AM – 1:15 PM
(55) Effect of Student-Led Community Workshops on Knowledge and Attitudes About Opioid Overdose
Favorite
11:45 AM – 1:15 PM
(56) Destruction by Designer Benzodiazepines: A Case Report
Favorite
11:45 AM – 1:15 PM
(57) Alcohol Withdrawal and Benzodiazepine Use in an Acute Inpatient Rural Hospital
Favorite
11:45 AM – 1:15 PM
(58) Consequences of Benzodiazepine-Induced Neurological Dysfunction: An Internet Survey
Favorite
11:45 AM – 1:15 PM
(59) Characterizing the Contribution of Alcohol Use towards Distinct Neurocognitive Profiles
Favorite
11:45 AM – 1:15 PM
(60) Improving Well Childcare, Newborn and Maternal Outcomes with COMPASSION Model
Favorite
11:45 AM – 1:15 PM
(61) Therapeutic Pathways for Children Affected by Caregiver Substance Misuse
Favorite
11:45 AM – 1:15 PM
(62) Improving Substance Use Screening using S2BI in a Pediatric Primary Care Clinic
Favorite
11:45 AM – 1:15 PM
(63) Disparities in Toxicology Testing Results During the Birthing Hospitalization
Favorite
11:45 AM – 1:15 PM
(64) Assessing Barriers to Primary Care for Reproductive-Aged Women with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(65) A Multi-level Analysis of MOUD Use Among Pregnant Individuals in Treatment
Favorite
11:45 AM – 1:15 PM
(66) Fentanyl Fat Sequestration in Pregnancy and Post-Pregnancy Urine Drug Test Results
Favorite
11:45 AM – 1:15 PM
(67) Put a Patch on and See What Happens: Harm Reduction for TUD
Favorite
11:45 AM – 1:15 PM
(68) Addressing Tobacco Use Disorder in SUD Treatment: Talking about Tobacco
Favorite
11:45 AM – 1:15 PM
(69) Social Media for Smoking Cessation among Adult Smokers in the United States
Favorite
11:45 AM – 1:15 PM
(70) Bridging Patient and Physician Perspectives on Addiction Recovery and Spirituality
Favorite
11:45 AM – 1:15 PM
(71) Community Pharmacists’ Attitudes toward and Practice of Pharmacy-Based Harm Reduction
Favorite
11:45 AM – 1:15 PM
(72) Healthcare Attitudes on Reporting Impaired Colleagues
Favorite
11:45 AM – 1:15 PM
(73) Substance Use and Mental Health Among Middle- and High-Schoolers: A Survey Study
Favorite
11:45 AM – 1:15 PM
(74) Evaluating a Pre-Arrest Diversion Program: Who Benefits and Does it Work?
Favorite
11:45 AM – 1:15 PM
(75) Barriers to Recovery Following an Overdose: A Qualitative Study
Favorite
11:45 AM – 1:15 PM
(76) Evaluating Admissions for Opioid and Substance Use Disorders under Michigan’s Opioid Laws
Favorite
11:45 AM – 1:15 PM
(77) Assessing Inpatient Dispositions of Opioid and Polysubstance Use Under Michigan Opioid Laws
Favorite
11:45 AM – 1:15 PM
(78) Acute Opioid Withdrawal after Liposuction in a Patient on Extended Release Buprenorphine
Favorite
11:45 AM – 1:15 PM
(79) Buprenorphine/Naloxone Induction of OUD Patients Using Telehealth in the Fentanyl Era
Favorite
11:45 AM – 1:15 PM
(80) Comparison of a Hospital-Based 3, 5, and 7-Day Buprenorphine Microinduction Protocol
Favorite
11:45 AM – 1:15 PM
(81) Examination of Patient Reported Buprenorphine Dosing in Patients with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(82) Feasibility of Microdose Buprenorphine Starts with Methadone and Illicit Opioid Use
Favorite
11:45 AM – 1:15 PM
(83) Israel's First Low-Dose Buprenorphine Inductions for Fentanyl, Oxycodone and Tramadol Use
Favorite
11:45 AM – 1:15 PM
(84) Patient Related Factors behind Racial Inequities of Buprenorphine Treatment in Primary Care
Favorite
11:45 AM – 1:15 PM
(85) Rapid Methadone Induction in the Hospital Setting: A Retrospective Observational Analysis
Favorite
11:45 AM – 1:15 PM
(86) XR-BUP in the Colorado Department of Corrections (CDOC): Lessons from >500 injections
Favorite
11:45 AM – 1:15 PM
(87) A Qualitative Study on the Trajectories of People with OUD after Incarceration
Favorite
11:45 AM – 1:15 PM
(88) A Multidisciplinary Approach for OUD among Justice Involved Individuals in Rural Settings
Favorite
11:45 AM – 1:15 PM
(89) A Quality Improvement Initiative: Embedding OUD treatment in academic primary care
Favorite
11:45 AM – 1:15 PM
(90) Effects of Opioid and Stimulant Use Disorders on COVID-19 Reinfection and Outcomes
Favorite
11:45 AM – 1:15 PM
(91) Insomnia is Associated with Neurofunctional Differences among Females Treated for OUD
Favorite
11:45 AM – 1:15 PM
(92) Patient-Directed Discharges are Associated with Poor Health Outcomes in Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(93) Patients' Illness Models Influence Their Beliefs in Opioid Use Disorder Treatment Efficacy
Favorite
11:45 AM – 1:15 PM
(94) Stress Among Persons with Opioid Use Disorder during the First Year Postpartum
Favorite
11:45 AM – 1:15 PM
(95) Qualitative Analysis of Reasons Why Patients Decline ASAM Levels of Care
Favorite
11:45 AM – 1:15 PM
(96) Emergency Department Buprenorphine-Naloxone for Non-Fatal Opioid Overdose Survivors
Favorite
11:45 AM – 1:15 PM
(97) Binge Drinking, Intimate Partner Violence, and Sex in Transgender Population in China
Favorite
11:45 AM – 1:15 PM
(98) Oral Antibiotic Prescription for Persons Who Use Drugs Pursuing Patient-Directed Discharge
Favorite
11:45 AM – 1:15 PM
(99) Pharmacological Cognitive Enhancement: Perceptions of Stimulant Misuse and Integrity
Favorite
11:45 AM – 1:15 PM
(100) The Ecological Validity of the Yale Food Addiction Scale 2.0
Favorite
11:45 AM – 1:15 PM
(101) Treated Me like a Junkie: Factors Associated with Harm Reduction among PWID
Favorite
11:45 AM – 1:15 PM
(102) Validation of Online Version of Addiction Severity Index-6 in Chilean Population
Favorite
11:45 AM – 1:15 PM
(103) Impact of Co-occurring Substance Use Disorder on Inpatient Adolescent Psychiatry Outcomes
Favorite
Back to Top
